Rapt Therapeutics Stock Market Value
| RAPT Stock | USD 1.05 0.02 1.87% |
| Symbol | RAPT |
RAPT Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of RAPT Therapeutics. If investors know RAPT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about RAPT Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.78) | Quarterly Revenue Growth (1.00) | Return On Assets (0.47) | Return On Equity (0.80) |
The market value of RAPT Therapeutics is measured differently than its book value, which is the value of RAPT that is recorded on the company's balance sheet. Investors also form their own opinion of RAPT Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is RAPT Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because RAPT Therapeutics' market value can be influenced by many factors that don't directly affect RAPT Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between RAPT Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if RAPT Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RAPT Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
RAPT Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to RAPT Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of RAPT Therapeutics.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in RAPT Therapeutics on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding RAPT Therapeutics or generate 0.0% return on investment in RAPT Therapeutics over 30 days. RAPT Therapeutics is related to or competes with Connect Biopharma, Tyra Biosciences, Xilio Development, Mineralys Therapeutics,, Molecular Partners, AN2 Therapeutics, and Pharvaris. RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing... More
RAPT Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure RAPT Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess RAPT Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 61.07 | |||
| Value At Risk | (11.56) | |||
| Potential Upside | 10.0 |
RAPT Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for RAPT Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as RAPT Therapeutics' standard deviation. In reality, there are many statistical measures that can use RAPT Therapeutics historical prices to predict the future RAPT Therapeutics' volatility.| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (1.25) | |||
| Total Risk Alpha | (2.03) | |||
| Treynor Ratio | (0.32) |
RAPT Therapeutics Backtested Returns
RAPT Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.11, which implies the company had a -0.11% return per unit of standard deviation over the last 3 months. RAPT Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check RAPT Therapeutics' Mean Deviation of 5.65, market risk adjusted performance of (0.31), and Variance of 68.87 to confirm the risk estimate we provide. The firm holds a Beta of 3.0, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, RAPT Therapeutics will likely underperform. At this point, RAPT Therapeutics has a negative expected return of -0.93%. Please make sure to check RAPT Therapeutics' treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if RAPT Therapeutics performance from the past will be repeated at future time.
Auto-correlation | -0.72 |
Almost perfect reverse predictability
RAPT Therapeutics has almost perfect reverse predictability. Overlapping area represents the amount of predictability between RAPT Therapeutics time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of RAPT Therapeutics price movement. The serial correlation of -0.72 indicates that around 72.0% of current RAPT Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.72 | |
| Spearman Rank Test | -0.98 | |
| Residual Average | 0.0 | |
| Price Variance | 0.48 |
RAPT Therapeutics lagged returns against current returns
Autocorrelation, which is RAPT Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting RAPT Therapeutics' stock expected returns. We can calculate the autocorrelation of RAPT Therapeutics returns to help us make a trade decision. For example, suppose you find that RAPT Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
RAPT Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If RAPT Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if RAPT Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in RAPT Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
RAPT Therapeutics Lagged Returns
When evaluating RAPT Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of RAPT Therapeutics stock have on its future price. RAPT Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, RAPT Therapeutics autocorrelation shows the relationship between RAPT Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in RAPT Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.